Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.

Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Abstract Text:

    sandra blancoSandra Blanco,rosa peninRosa Penin,irma casasIrma Casas,dolores Dolores , romero Romero,

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. BACKGROUND: It has been extensively reported that antihypertensive drugs reduce proteinuria and glomerulosclerosis (GS) in many experimental nephropathies and in humans. However, the role of calcium channel blockers (CCBs) in the prevention of proteinuria and GS remains controversial and in most cases only dihidropyridine-CCBs are studied. Few studies have reported whether the time at which drug administration is initiated plays a role in the reduction of proteinuria and GS. METHODS: Fifty-six male Obese Zucker rats (OZR) were used as a model of spontaneous type 2 diabetes-related nephropathy. Biochemical and histological analysis were performed to compare the efficacy of a non-dihydropyridine-CCB diltiazem [DZM; 100 mg/kg body weight (BW)/day], an ACEI quinapril (10 mg/kg BW/day), or both in diminishing proteinuria and GS, and to determine their role in effective prevention and treatment. RESULTS: Only quinapril was able to diminish proteinuria. As far as histological lesions, both treatments were effective, although only quinapril prevented GS. The combination of quinapril plus DZM did not demonstrate any beneficial effects. Surprisingly, quinapril ameliorated the damage of podocytes whereas DZM did not, thus leading to doubt concerning the efficiency of DZM in long-term studies. Nonetheless, the combination of quinapril plus DZM demonstrated a greater reduction in podocyte damage than treatment with DZM alone, which shows an interesting association in the prevention of longer-term glomerular damage. Few differences were found between prevention and treatment. CONCLUSIONS: Quinapril, but not DZM, was able to diminish proteinuria in OZR. Both treatments were effective in diminishing GS, although only quinapril totally prevented it. The combination of both drugs prevented long-term glomerular damage, which is intriguing.

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Publishing Authors By Initials

    s blancoS Blanco,r peninR Penin,i casasI Casas,d D ,r romeroR Romero,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Kidney international. Supplement

    VOLUME:

    Page Numbers: 27-31

    Journal Abbreviation: Kidney Int. Suppl.

    ISSN: 0098-6577

    DAY: 4

    MONTH: Dec

    YEAR: 2002

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7508622

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.

    AFFILIATION: Nephrology Department, Pathology Department, and Intern Department, Hospital Germans Trias i Pujol, Barcelona, Spain.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Kidney Int Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News